ROCHE HOLDINGS AG
RHHVF442.2001.84% ( -8.300 )
ROCHE HOLDINGS AG (RHHVF)
- Open
- 455.732
- High
- 455.732
- Low
- 437.000
- Prev. Close
- 450.500
- Volume
- 63.59K
- Turnover
- 27.93M
- Avg Price
- 439.281
- Bid/Ask Ratio
- --
- Amplitude
- 4.16%
- 52wk High
- 490.330
- Volume Ratio
- 60.60
- Turnover Ratio
- 0.01%
ROCHE HOLDINGS AG Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$466.565.51%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · Jun 4 at 02:35 AM
Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection | RHHBY Stock News
- StockTitan · Jun 1 at 04:01 PM
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting | RHHBY Stock News
- nasdaq · Jun 1 at 09:45 AM
Genentech Presents Updated Clinical Results Of Enicepatide And Petrelintide At ADA 2026
- Fiercepharma · May 13 at 03:50 PM
BeOne's Venclexta challenger Beqalzi nets FDA approval
- benzinga_article · May 12 at 09:07 AM
Roche, Eli Lilly Alzheimer's Blood Test Cleared In Europe For Earlier Detection
- StockTitan · May 11 at 04:00 PM
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217) | RHHBY Stock News
